Literature DB >> 26614223

Pretreatment serum xanthophyll concentrations as predictors of head and neck cancer recurrence and survival.

Anna E Arthur1,2, Emily L Bellile3,4, Laura S Rozek2,5, Karen E Peterson2,6, Jianwei Ren7, Ethan Harris7, Christie Mueller7, Shruti Jolly8, Lisa A Peterson5, Gregory T Wolf5, Zora Djuric2,7.   

Abstract

BACKGROUND: The purpose of this study was to examine associations of pretreatment serum carotenoids, tocopherols, and quercetin with prognosis in 154 patients newly diagnosed with head and neck cancer.
METHODS: Pretreatment blood and health surveys were collected. Serum micronutrients were measured by high performance liquid chromatography. Data on recurrence and death were collected annually. Cox proportional hazards models measured associations of serum nutrient concentrations with recurrence and overall survival.
RESULTS: During a median follow-up time of 37 months, there were 32 recurrences and 27 deaths. After controlling for covariates, subjects with high versus low serum xanthophyll and total carotenoid concentrations had significantly longer recurrence-free time (p = .002 and p = .02, respectively). Overall survival time was significantly longer in patients with high versus low serum xanthophyll concentrations (p = .02).
CONCLUSION: Future research should evaluate the possible benefits of interventions to increase intakes of rich food sources of xanthophylls in this patient population.
© 2015 Wiley Periodicals, Inc. Head Neck 38: E1591-E1597, 2016. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  head and neck cancer; quercetin; recurrence; serum micronutrients; survival; xanthophylls

Mesh:

Substances:

Year:  2015        PMID: 26614223      PMCID: PMC4844799          DOI: 10.1002/hed.24283

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  38 in total

1.  Multitarget effects of quercetin in leukemia.

Authors:  Victor Maso; Andrana Karla Calgarotto; Gilberto Carlos Franchi; Alexandre Eduardo Nowill; Paulo Latuf Filho; José Vassallo; Sara Teresinha Olalla Saad
Journal:  Cancer Prev Res (Phila)       Date:  2014-10-07

2.  More Americans are eating "5 a day" but intakes of dark green and cruciferous vegetables remain low.

Authors:  C S Johnston; C A Taylor; J S Hampl
Journal:  J Nutr       Date:  2000-12       Impact factor: 4.798

3.  The role of vegetable and fruit consumption and other habits on survival following the diagnosis of oral cancer: a prospective study in Spain.

Authors:  M Sandoval; R Font; M Mañós; M Dicenta; M J Quintana; F X Bosch; X Castellsagué
Journal:  Int J Oral Maxillofac Surg       Date:  2008-10-31       Impact factor: 2.789

4.  Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma.

Authors:  Sonia A Duffy; David L Ronis; Scott McLean; Karen E Fowler; Stephen B Gruber; Gregory T Wolf; Jeffrey E Terrell
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

5.  Fruit and vegetable intake and head and neck cancer risk in a large United States prospective cohort study.

Authors:  Neal D Freedman; Yikyung Park; Amy F Subar; Albert R Hollenbeck; Michael F Leitzmann; Arthur Schatzkin; Christian C Abnet
Journal:  Int J Cancer       Date:  2008-05-15       Impact factor: 7.396

Review 6.  Cancer chemoprevention.

Authors:  S M Lippman; S E Benner; W K Hong
Journal:  J Clin Oncol       Date:  1994-04       Impact factor: 44.544

7.  Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands.

Authors:  M G Hertog; P C Hollman; M B Katan; D Kromhout
Journal:  Nutr Cancer       Date:  1993       Impact factor: 2.900

8.  Pretreatment dietary patterns, weight status, and head and neck squamous cell carcinoma prognosis.

Authors:  Anna E Arthur; Karen E Peterson; Laura S Rozek; Jeremy M G Taylor; Emily Light; Douglas B Chepeha; James R Hébert; Jeffrey E Terrell; Gregory T Wolf; Sonia A Duffy
Journal:  Am J Clin Nutr       Date:  2012-12-26       Impact factor: 7.045

9.  Flavonol and flavone intakes in US health professionals.

Authors:  Laura Sampson; Eric Rimm; Peter C H Hollman; Jeanne H M de Vries; Martijn B Katan
Journal:  J Am Diet Assoc       Date:  2002-10

10.  Prognostic importance of comorbidity in a hospital-based cancer registry.

Authors:  Jay F Piccirillo; Ryan M Tierney; Irene Costas; Lori Grove; Edward L Spitznagel
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

View more
  5 in total

1.  Dietary behaviors and survival in people with head and neck cancer: Results from Head and Neck 5000.

Authors:  Samantha Lang; Sarah Schimansky; Rhona Beynon; Christopher Penfold; Amy Davies; Andrea Waylen; Steven Thomas; Miranda Pring; Michael Pawlita; Tim Waterboer; Andrew R Ness
Journal:  Head Neck       Date:  2019-01-30       Impact factor: 3.147

2.  Pretreatment Dietary Patterns Are Associated with the Presence of Nutrition Impact Symptoms 1 Year after Diagnosis in Patients with Head and Neck Cancer.

Authors:  Sylvia L Crowder; Kalika P Sarma; Alison M Mondul; Yi Tang Chen; Zonggui Li; M Yanina Pepino; Katie R Zarins; Gregory T Wolf; Laura S Rozek; Anna E Arthur
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-07-17       Impact factor: 4.254

3.  Feasibility Outcomes of a Pilot Randomized Clinical Trial to Increase Cruciferous and Green Leafy Vegetable Intake in Posttreatment Head and Neck Cancer Survivors.

Authors:  Sylvia L Crowder; Andrew D Frugé; Katherine G Douglas; Yi Tang Chen; Laura Moody; Ashley Delk-Licata; John W Erdman; Molly Black; William R Carroll; Sharon A Spencer; Julie L Locher; Wendy Demark-Wahnefried; Laura Q Rogers; Anna E Arthur
Journal:  J Acad Nutr Diet       Date:  2019-01-17       Impact factor: 4.910

Review 4.  Dietary Carotenoids in Head and Neck Cancer-Molecular and Clinical Implications.

Authors:  Katarzyna Starska-Kowarska
Journal:  Nutrients       Date:  2022-01-26       Impact factor: 5.717

5.  Higher carbohydrate intake is associated with increased risk of all-cause and disease-specific mortality in head and neck cancer patients: results from a prospective cohort study.

Authors:  Anna E Arthur; Amy M Goss; Wendy Demark-Wahnefried; Alison M Mondul; Kevin R Fontaine; Yi Tang Chen; William R Carroll; Sharon A Spencer; Laura Q Rogers; Laura S Rozek; Gregory T Wolf; Barbara A Gower
Journal:  Int J Cancer       Date:  2018-04-17       Impact factor: 7.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.